<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001062.v1.p1" parentStudy="phs001062.v1.p1" createDate="2016-01-25" modDate="2016-10-11">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Patrick Ellinor, MD, PhD</td><td>Massachusetts General Hospital, Boston, MA, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Steven Lubitz, MD</td><td>Massachusetts General Hospital, Boston, MA, USA</td></tr>
		<tr><td>Funding Source</td><td>R01HL092577</td><td>National Heart Lung and Blood Institute, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R01HL092577S1</td><td>National Heart Lung and Blood Institute, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>R21DA027021</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>NHLBI TOPMed: MGH Atrial Fibrillation Study</StudyNameEntrez>
	<StudyNameReportPage>NHLBI TOPMed: Massachusetts General Hospital (MGH) Atrial Fibrillation Study</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Massachusetts General Hospital (MGH) Atrial Fibrillation Study was initiated in 2001. The study has enrolled serial probands, unaffected and affected family members with atrial fibrillation. At enrollment participants undergo a structured interview to systematically capture their past medical history, AF treatments, and family history. An electrocardiogram is performed; the results of an echocardiogram are obtained; and blood samples are obtained.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Probands were included if they had a history of atrial fibrillation. In participants with an extensive family history of atrial fibrillation, additional affected and unaffected family members were enrolled.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="20173747"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22544366"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25124494"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24486271"/>
		</Publication>
		<Publication>
			<Pubmed pmid="16133178"/>
		</Publication>
		<Publication>
			<Pubmed pmid="15629379"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Atrial Fibrillation"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Patrick Ellinor, MD, PhD</AttName>
			<Institution>Massachusetts General Hospital, Boston, MA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Steven Lubitz, MD</AttName>
			<Institution>Massachusetts General Hospital, Boston, MA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01HL092577</AttName>
			<Institution>National Heart Lung and Blood Institute, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01HL092577S1</AttName>
			<Institution>National Heart Lung and Blood Institute, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R21DA027021</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01HL104156</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>K24HL105780</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U01HL65962</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>K23HL071632</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>K23HL114724</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>13EIA14220013</AttName>
			<Institution>American Heart Association, National Center, Dallas, TX, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>14CVD01</AttName>
			<Institution>Fondation Leducq, Paris, France</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMB-IRB" longName="Health/Medical/Biomedical (IRB)"/>
		<ConsentGroup groupNum="2" shortName="DS-AF-IRB-RD" longName="Disease-Specific (Atrial Fibrillation, IRB, RD)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs001062.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001062.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001062.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health/Medical/Biomedical (IRB)</ConsentName>
        <ConsentAbbrev>HMB-IRB</ConsentAbbrev>
        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the MGH AF Study data deposited in dbGaP is restricted to research on associations between phenotypes and genotypes. MGH AF Study data may not be used to investigate individual participant genotypes, individual pedigree structures, perceptions of racial/ethnic identity, non-maternity/paternity, and of variables that could be considered as stigmatizing an individual or group. All research must be related to the etiology and prevention of morbidity and mortality of the U.S. population consistent with the demographic distribution in the MGH AF Study. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted).</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="2">
        <ConsentName>Disease-Specific (Atrial Fibrillation, IRB, RD)</ConsentName>
        <ConsentAbbrev>DS-AF-IRB-RD</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Atrial Fibrillation and related disorders.
Requestor must provide documentation of local IRB approval.
Data use is limited to research related to atrial fibrillation and cardiovascular disease.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
      <ParticipantSet groupNum-REF="999">
        <ConsentName>Exchange Area</ConsentName>
        <ConsentAbbrev>EA</ConsentAbbrev>
        <UseLimitation>Use by NHLBI WGS study investigators only
There are two consent groups for this study: HMB-IRB and DS-AF-IRB-RD (Disease Specific Atrial Fibrillation-IRB-Related Diseases
For HMB-IRB:
Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor must provide documentation of local IRB approval.
Use of the MGH AF Study data deposited in dbGaP is restricted to research on associations between phenotypes and genotypes. MGH AF Study data may not be used to investigate individual participant genotypes, individual pedigree structures, perceptions of racial/ethnic identity, non-maternity/paternity, and of variables that could be considered as stigmatizing an individual or group. All research must be related to the etiology and prevention of morbidity and mortality of the U.S. population consistent with the demographic distribution in the MGH AF Study. Data users will be required to obtain IRB approval for their projects from their respective institutions (please note that only full or expedited approvals will be accepted). 
For DS-AF-IRB-RD:
Use of the data must be related to Atrial Fibrillation and related disorders.
Requestor must provide documentation of local IRB approval.
Data use is limited to research related to atrial fibrillation and cardiovascular disease.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>
  <Documents>
    <Document phd="phd006969.1" type="protocol" createDate="2016-10-05" modDate="2016-10-11" urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd006969.1" urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs001062.v1.p1&amp;phd=6969">
      <OrigName>TOPMed_document.txt</OrigName>
      <DisplayName>TOPMed Whole Genome Sequencing Project</DisplayName>
      <Description>TOPMed Whole Genome Sequencing Project</Description>
      <displayStatus>public</displayStatus>
      <xmlStatus>public</xmlStatus>
    </Document>
  </Documents>



</Study>

</Studies>

</GaPExchange>
